Full Title
A Study of ELA026 in Participants with Relapsed/refractory (R/R) T/NK-cell malignancies (TCMs)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Steven Horowitz’s office at 646-608-3725.
Protocol
26-207
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Co-Investigators
Locations
ClinicalTrials.gov ID
NCT07465835
ClinicalTrials.gov